FDA Gives Emergency-Use Authorization to Becton Dickinson Covid-19 Antigen Test
July 06 2020 - 3:20PM
Dow Jones News
By Kimberly Chin
The U.S. Food and Drug Administration has granted emergency-use
authorization to Becton Dickinson & Co. for its Covid-19
point-of-care antigen test, the second such test to get
authorization under the program, the health regulator said.
The test can be used on Becton's Veritor Plus System, a device
that provides test results in less than 15 minutes and is targeted
for healthcare providers, lab workers in physician offices and
others in the health sector, the company said early Monday.
"Expanding America's testing capabilities is the result of
partnership and ingenuity between the federal government, private
sector and academia. Today's authorization is another achievement
of that work," said FDA Commissioner Stephen Hahn.
An antigen test looks for the disease itself, as opposed to
antibody tests that look for traces of past exposure.
In May, the agency granted emergency-use authorization to Quidel
Corp. for the first antigen test for the Covid-19 virus.
Write to Kimberly Chin at kimberly.chin@wsj.com
(END) Dow Jones Newswires
July 06, 2020 15:05 ET (19:05 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Apr 2023 to Apr 2024
